In focus · trending topic

Editas Medicine

62 stories · following the connections

Editas Medicine to Present at the 35th Annual J.P. Morgan Healthcare Conference

By Nasdaq OMXJan 4, 2017, 1:06 PM UTC

Editas Medicine Extends CRISPR Genome Editing Leadership Through Licensing of New CRISPR Technologies

By Nasdaq OMXDec 19, 2016, 12:00 PM UTC

Editas Medicine to Present at the Stifel Healthcare Conference 2016

By Nasdaq OMXNov 9, 2016, 1:00 PM UTC

Editas Medicine Announces Third Quarter 2016 Results and Update

By Nasdaq OMXNov 7, 2016, 9:01 PM UTC

Editas Medicine to Host Conference Call Discussing Third Quarter 2016 Corporate Update and Results

By Nasdaq OMXOct 31, 2016, 8:01 PM UTC

Editas Medicine to Present Data on CRISPR/Cas9-mediated Gene Editing in Hematopoietic Stem/Progenitor Cells at ESGCT-ISSCR 2016

By Nasdaq OMXOct 17, 2016, 11:30 AM UTC

Editas Medicine Reports Inducement Grant to New Chief Medical Officer

By Nasdaq OMXOct 6, 2016, 12:00 PM UTC

Editas Medicine to Present at the Jefferies Gene Editing/Therapy Summit

By Nasdaq OMXOct 3, 2016, 8:01 PM UTC